Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer

Natasha D. Buchanan, Rebecca Block, Ashley Wilder Smith, Eric Tai

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Adolescents (aged 15-19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent's decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence.

    Original languageEnglish (US)
    JournalPediatrics
    Volume133
    Issue numberSUPPL. 3
    DOIs
    StatePublished - Jun 1 2014

    Fingerprint

    Clinical Trials
    Psychology
    Neoplasms
    Adherence
    Enrollment
    Cancer
    Psychological

    Keywords

    • Adherence
    • Adolescent
    • Cancer survivors
    • Clinical trial
    • Enrollment
    • Psychosocial

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Arts and Humanities (miscellaneous)

    Cite this

    Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer. / Buchanan, Natasha D.; Block, Rebecca; Smith, Ashley Wilder; Tai, Eric.

    In: Pediatrics, Vol. 133, No. SUPPL. 3, 01.06.2014.

    Research output: Contribution to journalArticle

    Buchanan, Natasha D. ; Block, Rebecca ; Smith, Ashley Wilder ; Tai, Eric. / Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer. In: Pediatrics. 2014 ; Vol. 133, No. SUPPL. 3.
    @article{f35f1bee6a574cd3a06b5c6022935d14,
    title = "Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer",
    abstract = "Adolescents (aged 15-19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent's decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence.",
    keywords = "Adherence, Adolescent, Cancer survivors, Clinical trial, Enrollment, Psychosocial",
    author = "Buchanan, {Natasha D.} and Rebecca Block and Smith, {Ashley Wilder} and Eric Tai",
    year = "2014",
    month = "6",
    day = "1",
    doi = "10.1542/peds.2014-0122I",
    language = "English (US)",
    volume = "133",
    journal = "Pediatrics",
    issn = "0031-4005",
    publisher = "American Academy of Pediatrics",
    number = "SUPPL. 3",

    }

    TY - JOUR

    T1 - Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer

    AU - Buchanan, Natasha D.

    AU - Block, Rebecca

    AU - Smith, Ashley Wilder

    AU - Tai, Eric

    PY - 2014/6/1

    Y1 - 2014/6/1

    N2 - Adolescents (aged 15-19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent's decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence.

    AB - Adolescents (aged 15-19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent's decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence.

    KW - Adherence

    KW - Adolescent

    KW - Cancer survivors

    KW - Clinical trial

    KW - Enrollment

    KW - Psychosocial

    UR - http://www.scopus.com/inward/record.url?scp=84901769151&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84901769151&partnerID=8YFLogxK

    U2 - 10.1542/peds.2014-0122I

    DO - 10.1542/peds.2014-0122I

    M3 - Article

    VL - 133

    JO - Pediatrics

    JF - Pediatrics

    SN - 0031-4005

    IS - SUPPL. 3

    ER -